Document is current
Any future updates will be listed below
-
Authors
Gilliam, Elisa
Achenbach, Pascal
Suemmermann, Gernot J.
Wessely, Manuel N.
Rossmanith, Peter
Dohrn, Maike F.
Schulz, Jörg B.
Waschbisch, Anne
Brunkhorst, Robert
-
Clinical Trials BETA
Clinical trials referenced in this document:
drks00027345 at German Clinical Trials RegisterDocuments that mention this clinical trial
Assessing hand motor function in chronic immune-mediated neuropathies: a proof-of-concept study using a data glove
https://doi.org/10.1186/s12984-024-01518-3
-
Funding
Funding for this research was provided by:
Universitätsklinikum RWTH Aachen
- License Information
-
More Information
Article History
Received: 3 July 2024
Accepted: 27 November 2024
First Online: 20 December 2024
Declarations
:
: The study was conducted according to the Declaration of Helsinki and was finally approved by the Ethics Committee of the University Hospital Aachen on of March 10, 2022 (EK 439/21). Patients gave written informed consent to participate in the study before inclusion.
: Not applicable.
: JBS serves at advisory boards for Reata, Biogen, Eisai and Roche. MFD received financial reimbursement for consulting and advisory board activities and travel support to attend scientific meetings by Akcea Therapeuticals Inc., Alnylam Pharmaceuticals Inc., Amicus Therapeutics, Astra Zeneca Therapeutics, Pfizer Pharmaceuticals, and Sobi. MFD further received research funding by Pfizer Pharmaceuticals (ASPIRE 2018). PA received travel support to attend scientific meetings by Alnylam Pharmaceuticals Inc. GJS received the student scholarship <i>Miteinander durchs Studium</i> of the Faculty of Mechanical Engineering, RWTH Aachen. GJS and MNW are founders of Cynteract® GmbH and are working for that company. During the study period, EG received the <i>Deutschlandstipendium,</i> a student scholarship of the RWTH Aachen.
